1. Home
  2. MCHX vs LNSR Comparison

MCHX vs LNSR Comparison

Compare MCHX & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

SELL

Current Price

$1.44

Market Cap

60.3M

ML Signal

SELL

Logo LENSAR Inc.

LNSR

LENSAR Inc.

SELL

Current Price

$5.28

Market Cap

71.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MCHX
LNSR
Founded
2003
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
71.7M
IPO Year
2003
2005

Fundamental Metrics

Financial Performance
Metric
MCHX
LNSR
Price
$1.44
$5.28
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $11.00
AVG Volume (30 Days)
25.8K
★ 65.3K
Earning Date
11-10-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.56
Revenue
★ $90,291,000.00
$58,435,000.00
Revenue This Year
$16.21
$4.22
Revenue Next Year
$29.69
$19.43
P/E Ratio
★ N/A
$8.88
Revenue Growth
N/A
★ 9.24
52 Week Low
$1.15
$4.30
52 Week High
$2.00
$12.94

Technical Indicators

Market Signals
Indicator
MCHX
LNSR
Relative Strength Index (RSI) 50.94 41.61
Support Level $1.25 $5.17
Resistance Level $1.52 $6.29
Average True Range (ATR) 0.13 0.36
MACD 0.01 -0.02
Stochastic Oscillator 43.33 56.00

Price Performance

Historical Comparison
MCHX
LNSR

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: